#ImplantFiles | Defective insulin pumps: hospitals intervene to alert

The daughter of Delhi-based lawyer Alishan Naqvee has been using an insulin pump since she was diagnosed with type 1 diabetes at the age of six. She is now nine years old and is able to carry out the activities expected of a child with the help of a small electronic device that infuses her with insulin all day long.

In September 2017, his father remembers that they had received an e-mail from Medtronic on the international recall of his MiniMed infusion set, indicating that these would be replaced by all patients using them . "When e-mail arrived, we had three or four spare infusion sets. The representative of the company came the same day and gave us replacements. Medtronic is the only company that provides insulin pumps in India and it is the one we have always used for our daughter, "said Naqvee.

Shrey Ahuja, 22 years old and residing in Delhi, says that he was diagnosed with diabetes when he was almost three years old.He has been using the Medtronic insulin pump since the age of nine.In my case, Medtronic has replaced the spare cannulas that are attached to the body to infuse insulin.We had almost three boxes of cannulas at home and all were replaced free of charge, "he said.

of this reminder on the Central Drugs Standard Control Organization (CDSCO) website, intended to regulate recalls by displaying "medical advice alerts" but containing only 23 medical devices on his list e.
The insulin pump recall, in a nutshell, sums up the essence of Implant Files, a survey of the International Consortium of Investigative Journalists (ICIJ) and 59 companies The Indian Express, which outlines how almost every medical device is advertised, sold and surgically implanted under regulatory systems

Introduced in India in 2000, the Medtronic device consists of a disposable tube, a fitting tubing and a cannula, usually inserted under the skin, in the abdominal area. I dispense insulin to the body from the pump.
In September 2017, Medtronic announced that it was recalling specific batches of its MiniMed devices. The company said it had discovered that the device could trigger an excessive amount of insulin, which could lead to hypoglycemia. He said that about 10,000 infusion devices had been recalled in India from notified lots.

In particular, as part of the FDA's recall, the company said that the kits infusion used with his insulin pumps were voluntarily recalled due to problems with discontinuing the drug. The problem, he said, involved a vent membrane that could become clogged when priming and filling pipes. The recall had no effect on any pump or glucose sensor. Perfusion kits manufactured since April 2017 use an updated ventilation membrane design.

Elderly diabetologists in Delhi stated that Medtronic was not as proactive when recalling the MiniMed infusion set. Dr. Amrita Ghosh of the Fortis-C-DOC Center for Excellence in Diabetes, who is responsible for insulin pump therapy at the hospital, says they heard the news of the US Food and Drug Administration's recall. FDA) and informed Medtronic.

"We created a no-cost group for patients using the Medtronic insulin pump and this news was also broadcast by us the group. In all, about seven or eight patients used pumps in the affected lot and it was after our intervention that Medtronic contacted them. Shrey Ahuja is one of the people who got the replacements, "says Ghosh.

Dr. Ambarish Mittal, Senior Endocrinologist, reported hearing about the Medtronic Recall. According to him, even if the tip of the cannula or the perfusion wire becomes defective and that there is an insulin surge or insulin deficiency in the body, it can do a lot of damage .

"Although these are the smaller gears of the insulin pump system, they can wreak havoc in a patient. Immediate notification, in this case by Medtronic, is therefore imperative, as is immediate replacement of the recalled pump or part of the recalled insulin device, "said Mittal. [ad_2]
Source link